Previous Close | 0.6500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 5.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.6500 - 0.6500 |
Contract Range | N/A |
Volume | |
Open Interest | 100 |
CAMBRIDGE, Mass., May 07, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that company management will participate in a fireside chat at two upcoming investor conferences. Details are as follows:
CAMBRIDGE, Mass., May 07, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, May 14, 2024 to report its first quarter 2024 financial results and provide a corporate update.
Femasys (FEMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.